How much is Orchard Therapeutics worth in 2026?

Orchard Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Orchard Therapeutics raised?

Orchard Therapeutics has raised N/A in total funding across 1 funding rounds.

Orchard Therapeutics

Biotechnology

Orchard Therapeutics valuation and funding history | Last updated: March 10, 2023 | 1 funding rounds

Current Valuation

N/A

As of March 10, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$188.0M

Last Funding

Mar 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 10, 2023	PIPE	$188.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Orchard Therapeutics is currently valued at N/A as of March 10, 2023.

Track Orchard Therapeutics Valuation Updates

Get notified when Orchard Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Orchard Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Orchard Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Orchard Therapeutics Worth in 2026?

Orchard Therapeutics is a leading private company in the Biotechnology sector. Track Orchard Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Orchard Therapeutics Valuation is Determined

Private company valuations like Orchard Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.